
Research peptides
Thymosin alpha-1
Thymosin alpha-1 is a 28-amino-acid peptide originally isolated from thymic tissue. Its synthetic form is known as thymalfasin.
- Container
- Glass vial, crimp seal, flip-top cap
- Storage
- -20 °C, desiccated
- Paperwork
- Lot certificate (HPLC + mass spec) shown before you pay
Lot certificates
You’ll see American Peptides on the lab’s copy. They’re our supplier.
- 10 mg, lot TA110-0803: 99.78% purity (RP-HPLC), 10.87 mg measured, identity confirmed by mass spec. Issued 2026-08-28 by Bioviridian Inc.. Verify certificate COA7585
Our vials are filled from lots made by our supplier, American Peptides, and tested by Bioviridian Inc.The laboratory’s original certificate lists American Peptides as the vendor. Look up the code at bioviridians.com to check it.
What researchers study it for
- Chronic hepatitis B and C
- Sepsis
- Immune response to vaccines
- Adjunct use in cancer studies
- Dendritic cell and T-cell function
How it is thought to work
Thymosin alpha-1 is described as an immune modulator that affects several immune cell types. Reviews report that it acts through Toll-like receptors on myeloid and plasmacytoid dendritic cells, leading to cytokine production. In mouse work it promoted dendritic cell maturation and T-helper 1 antifungal responses. Part of the review literature is written by the manufacturer's staff.
Where the research stands
Approved in some countries as thymalfasin; no US approval found. A review reports thymalfasin as approved in more than 35 countries for hepatitis B and C. No approved product was found in Drugs@FDA, and FDA lists it among compounding substances with unresolved safety questions. A phase 3 sepsis trial of 1,106 adults found no clear mortality reduction.
Sources
- Dominari A, et al. (2020). Thymosin alpha 1: A comprehensive review of the literature. World Journal of Virology.
- Romani L, et al. (2004). Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling. Blood.
- Wu J, et al. (2025). The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial. BMJ.
- King R, Tuthill C. (2016). Immune Modulation with Thymosin Alpha 1 Treatment. Vitamins and Hormones.
Read more
For laboratory research use only. Not a drug, food, supplement or cosmetic; not for human or veterinary use. Nothing on this page is medical advice or a usage guide.
